Cite
HARVARD Citation
Pertega‐Gomes, N. et al. (2015). A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. Journal of pathology. 236 (4), pp. 517-530. [Online].